Treating unstable angina with detoxifying and blood-activating formulae: A randomized controlled trial.
- 2021-08-17
- Journal of ethnopharmacology 281
- Min Wu
- Shengjie Yang
- Guijian Liu
- Chun Gu
- Peng Ren
- Ran Zhao
- Yixi Zhao
- Yanwei Xing
- Longtao Liu
- Jiaqi Liang
- PubMed: 34416295
- DOI: 10.1016/j.jep.2021.114530
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 144
- Population
- 144 participants with unstable angina
- Methods
- Both groups were treated with standardized Western medicine; the experimental group was additionally treated with detoxifying and blood-activating Chinese medicine granules, which included 15 g of P. cuspidatum and 10 g of C. pinnatifida for 4 weeks
- Blinding
- Open-label
- Duration
- 4 weeks
- Funding
- Unclear
- Large Human Trial
Ethnopharmacological relevance
Detoxifying and blood-activating Chinese medicine granule formula, which includes 15 g of Polygonum cuspidatum Sieb. et Zucc. (Polygonum cuspidatum) and 10 g of Crataegus pinnatifida Bunge (Hawthorn), can relieve the symptoms and serve as supplementary treatment for unstable angina.Aim of the study
This study aimed to explore the role of detoxifying and blood-activating formulae in the treatment of unstable angina and the potential mechanism involved.Materials and methods
A total of 144 participants with unstable angina were randomly divided into experimental and control groups. Both groups were treated with standardized Western medicine; the experimental group was additionally treated with detoxifying and blood-activating Chinese medicine granules, which included 15 g of P. cuspidatum and 10 g of C. pinnatifida for 4 weeks. The primary endpoint was the frequency of weekly angina pectoris attacks before and after treatment. The secondary endpoints, also observed before and after treatment, included blood glucose, blood lipids, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-10, and adiponectin levels, as well as the ratio of pro/anti-inflammatory factors and evaluation scales of symptoms and syndromes in Chinese and Western medicine.Results
In both experimental and control groups, the frequency of weekly angina pectoris attacks was lower after treatment (P < 0.01), but with no significant intergroup difference (P = 0.10). After intervention, the hs-CRP, TNF-α, and IL-6 levels decreased, while the IL-10 and adiponectin levels significantly increased in the experimental group (P < 0.05 or 0.01). The ratios of the inflammatory factors significantly decreased after treatment, particularly in the experimental group (P < 0.01). Symptoms and syndromes were also ameliorated in the experimental group (P < 0.01), showing a significant difference from the control group (P < 0.01).Conclusions
Detoxifying and blood-activating formulae can reduce the frequency and relieve symptoms of unstable angina, and this mechanism may be related to a regulation of the balance of pro- and anti-inflammatory factors.Research Insights
Symptoms and syndromes were also ameliorated in the experimental group (P < 0.01), showing a significant difference from the control group (P < 0.01)
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 10 g/day
the IL-10 and adiponectin levels significantly increased in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the IL-10 and adiponectin levels significantly increased in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the frequency of weekly angina pectoris attacks was lower after treatment (P < 0.01), but with no significant intergroup difference (P = 0.10)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
The ratios of the inflammatory factors significantly decreased after treatment, particularly in the experimental group (P < 0.01)
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
Symptoms and syndromes were also ameliorated in the experimental group (P < 0.01), showing a significant difference from the control group (P < 0.01)
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 10 g/day
the IL-10 and adiponectin levels significantly increased in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the IL-10 and adiponectin levels significantly increased in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the frequency of weekly angina pectoris attacks was lower after treatment (P < 0.01), but with no significant intergroup difference (P = 0.10)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day
The ratios of the inflammatory factors significantly decreased after treatment, particularly in the experimental group (P < 0.01)
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 10 g/day
the hs-CRP, TNF-α, and IL-6 levels decreased... in the experimental group (P < 0.05 or 0.01)
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 10 g/day